Literature DB >> 7829879

Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds.

E C Bullen1, M T Longaker, D L Updike, R Benton, D Ladin, Z Hou, E W Howard.   

Abstract

The balance between matrix deposition and tissue turnover is fundamental in wound healing. It is likely that the balance between proteolytic enzymes and their inhibitors contributes to this balance. Matrix metalloproteinases are clearly important in tissue turnover, but their roles in wound healing are poorly understood. To investigate this, fluid from healing wounds resulting from mastectomies was collected from 1 h to 10 d post-surgery, and was analyzed for tissue inhibitor of metalloproteinases-1 concentrations. In all cases, tissue inhibitor of metalloproteinases-1 levels were initially comparable to those in serum, but increased rapidly to significantly higher levels within two days, with a tenfold average increase for five patients. On the other hand, zymography revealed that gelatinase A (72 kDa) levels increased moderately, whereas gelatinase B levels (92 kDa) decreased an average of twofold within 4 d. In contrast, fluid from chronic wounds had significantly more gelatinolytic activity, including lower-molecular-weight proteinase species that may represent activated or superactivated gelatinase fragments, as suggested by immunoprecipitation with specific antibodies. Tissue inhibitor of metalloproteinases-1 levels were lower in chronic than in healing wounds. These data may indicate that excess proteolysis in chronic wounds retards successful healing, and results from an imbalance of proteinase and inhibitors, as well as the presence of higher levels of activated metalloproteinases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7829879     DOI: 10.1111/1523-1747.ep12612786

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  45 in total

1.  Impaired wound contraction in stromelysin-1-deficient mice.

Authors:  K M Bullard; L Lund; J S Mudgett; T N Mellin; T K Hunt; B Murphy; J Ronan; Z Werb; M J Banda
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

Review 2.  Inflammation in nonhealing diabetic wounds: the space-time continuum does matter.

Authors:  G F Pierce
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

Review 3.  Clinical implications of matrix metalloproteinases.

Authors:  Malay Mandal; Amritlal Mandal; Sudip Das; Tapati Chakraborti; Chakraborti Sajal
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

Review 4.  [Fetal wound healing: current status and new perspectives].

Authors:  E A Huhn; C Jannowitz; H Boos; M A Papadopulos; H F Zeilhofer; J Henke; D Müller; L Kovacs; E Biemer; N A Papadopulos
Journal:  Chirurg       Date:  2004-05       Impact factor: 0.955

Review 5.  Collagenase and surgical disease.

Authors:  Timothy R Donahue; Jonathan R Hiatt; Ronald W Busuttil
Journal:  Hernia       Date:  2006-12       Impact factor: 4.739

Review 6.  Evolution or revolution? Adapting to complexity in wound management.

Authors:  Keith Harding; David Gray; John Timmons; Theresa Hurd
Journal:  Int Wound J       Date:  2007-06       Impact factor: 3.315

Review 7.  Vacuum-assisted closure home care training: a process to link education to improved patient outcomes.

Authors:  Kevin Y Woo; R Gary Sibbald
Journal:  Int Wound J       Date:  2008-06       Impact factor: 3.315

8.  In vitro and in vivo studies on matrix metalloproteinases interacting with small intestine submucosa wound matrix.

Authors:  Lei Shi; Sarah Ramsay; Ryan Ermis; Dennis Carson
Journal:  Int Wound J       Date:  2011-08-31       Impact factor: 3.315

9.  Development of a Novel Technique to Collect Proteases from Chronic Wounds.

Authors:  Thomas E Serena
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-12-01       Impact factor: 4.730

Review 10.  Biologic therapeutics and molecular profiling to optimize wound healing.

Authors:  Marie N Menke; Nathan B Menke; Cecelia H Boardman; Robert F Diegelmann
Journal:  Gynecol Oncol       Date:  2008-10-01       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.